The price you pay for Soliris may depend on factors such as whether you have health insurance. Financial assistance may be available to help you with the cost of Soliris. your treatment plan your ...

A board investigation found executives at Alexion Pharmaceuticals inappropriately encouraged staff to pressure customers into ordering its drug Soliris earlier than necessary to boost sales, reports ...

Teva and Samsung Bioepis are offering Epysqli, which is is a biosimilar to Alexion Pharmaceuticals' Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic ...

Samsung Bioepis and Teva have entered into a license, development and commercialization agreement for Epysqli (eculizumab-aagh), which is Samsung Bioepis’s biosimilar to Soliris. Samsung Bioepis will ...

The Food and Drug Administration on Friday granted expanded approval for Alexion Pharmaceuticals’ best-selling ultra-rare disease drug Soliris. The agency first approved Soliris in 2007 to treat ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Teva Pharmaceutical (NYSE:TEVA) and South Korean generic drugmaker Samsung Bioepis announced Monday the U.S. commercial availability of Epysqli, a biosimilar drug targeting AstraZeneca’s (NASDAQ:AZN) ...